Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation: the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study

AbstractAim. We tested the hypothesis that left ventricular hypertrophy (LVH) interferes with the antithrombotic effects of dabigatran and warfarin in patients

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Verdecchia, Paolo (VerfasserIn) , Brückmann, Martina (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: Europace
Year: 2017, Jahrgang: 20, Heft: 2, Pages: 253-262
ISSN:1532-2092
DOI:10.1093/europace/eux022
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/europace/eux022
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/europace/article/20/2/253/3829706
Volltext
Verfasserangaben:Paolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli, Giovanni Mazzotta, Gregory Y.H. Lip, Martina Brueckmann, Eva Kleine, Lars Wallentin, Michael D. Ezekowitz, Salim Yusuf, Stuart J. Connolly, and Giuseppe Di Pasquale

MARC

LEADER 00000caa a2200000 c 4500
001 1697209017
003 DE-627
005 20220818070154.0
007 cr uuu---uuuuu
008 200505r20182017xx |||||o 00| ||eng c
024 7 |a 10.1093/europace/eux022  |2 doi 
035 |a (DE-627)1697209017 
035 |a (DE-599)KXP1697209017 
035 |a (OCoLC)1341318592 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Verdecchia, Paolo  |e VerfasserIn  |0 (DE-588)120956937X  |0 (DE-627)169720886X  |4 aut 
245 1 0 |a Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation  |b the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study  |c Paolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli, Giovanni Mazzotta, Gregory Y.H. Lip, Martina Brueckmann, Eva Kleine, Lars Wallentin, Michael D. Ezekowitz, Salim Yusuf, Stuart J. Connolly, and Giuseppe Di Pasquale 
264 1 |c 2018 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.05.2020 
500 |a Online publish-ahead-of-print 17 May 2017 
520 |a AbstractAim. We tested the hypothesis that left ventricular hypertrophy (LVH) interferes with the antithrombotic effects of dabigatran and warfarin in patients 
534 |c 2017 
700 1 |a Brückmann, Martina  |d 1970-  |e VerfasserIn  |0 (DE-588)121145069  |0 (DE-627)705257290  |0 (DE-576)292557736  |4 aut 
773 0 8 |i Enthalten in  |t Europace  |d Oxford : Oxford Univ. Press, 1999  |g 20(2018), 2, Seite 253-262  |h Online-Ressource  |w (DE-627)320421171  |w (DE-600)2002579-8  |w (DE-576)252808975  |x 1532-2092  |7 nnas  |a Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study 
773 1 8 |g volume:20  |g year:2018  |g number:2  |g pages:253-262  |g extent:10  |a Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study 
856 4 0 |u https://doi.org/10.1093/europace/eux022  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://academic.oup.com/europace/article/20/2/253/3829706  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200505 
993 |a Article 
994 |a 2018 
998 |g 121145069  |a Brückmann, Martina  |m 121145069:Brückmann, Martina  |d 60000  |e 60000PB121145069  |k 0/60000/  |p 6 
999 |a KXP-PPN1697209017  |e 3658652934 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation","subtitle":"the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study","title_sort":"Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation"}],"person":[{"roleDisplay":"VerfasserIn","family":"Verdecchia","display":"Verdecchia, Paolo","given":"Paolo","role":"aut"},{"given":"Martina","role":"aut","roleDisplay":"VerfasserIn","family":"Brückmann","display":"Brückmann, Martina"}],"note":["Gesehen am 05.05.2020","Online publish-ahead-of-print 17 May 2017"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"10 S."}],"language":["eng"],"id":{"eki":["1697209017"],"doi":["10.1093/europace/eux022"]},"recId":"1697209017","relHost":[{"origin":[{"dateIssuedDisp":"1999-","publisher":"Oxford Univ. Press ; Harcourt ; Elsevier","dateIssuedKey":"1999","publisherPlace":"Oxford ; Burlington, Mass. ; Amsterdam"}],"pubHistory":["1.1999 -"],"disp":"Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) studyEuropace","part":{"pages":"253-262","volume":"20","issue":"2","extent":"10","text":"20(2018), 2, Seite 253-262","year":"2018"},"recId":"320421171","titleAlt":[{"title":"E-Pace"},{"title":"EP Europace"}],"id":{"eki":["320421171"],"issn":["1532-2092"],"zdb":["2002579-8"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 11.07.2023"],"title":[{"subtitle":"the European journal of pacing, arrhythmias and cardiac electrophysiology","title":"Europace","title_sort":"Europace"}]}],"name":{"displayForm":["Paolo Verdecchia, Gianpaolo Reboldi, Fabio Angeli, Giovanni Mazzotta, Gregory Y.H. Lip, Martina Brueckmann, Eva Kleine, Lars Wallentin, Michael D. Ezekowitz, Salim Yusuf, Stuart J. Connolly, and Giuseppe Di Pasquale"]},"origin":[{"dateIssuedDisp":"2018","dateIssuedKey":"2018"}]} 
SRT |a VERDECCHIADABIGATRAN2018